On January 31, 2018 Incyte Corporation (Nasdaq:INCY) reported an update to the conference call and webcast time for its fourth quarter and year end 2017 financial results to 8:00 a.m. ET on Thursday, February 15, 2018 (Press release, Incyte, JAN 31, 2018, View Source;p=RssLanding&cat=news&id=2329565 [SID1234523711]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The updated schedule for the press release and conference call/webcast is as follows:

•

Q4 & YE 2017 Press Release: February 15, 2018 at 7:00 a.m. ET
•

Q4 & YE 2017 Conference Call: February 15, 2018 at 8:00 a.m. ET
•

Domestic Dial-In Number: 877-407-3042
•

International Dial-In Number: 201-389-0864
•

Conference ID Number: 13675376

If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the U.S. is 877-660-6853 and the dial-in number for international callers is 201-612-7415. To access the replay you will need the conference ID number 13675376.

The live webcast with slides can be accessed at www.incyte.com under For Investors, Events and Presentations and will be available for replay for 30 days.